17 patents
Utility
Inhalable imatinib formulations, manufacture, and uses thereof
14 Nov 23
The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
Ben Dake, Ralph Niven
Filed: 15 Aug 22
Utility
Inhalable imatinib formulations, manufacture, and uses thereof
7 Nov 23
The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
Ben Dake, Ralph Niven, Andrew D. Levin
Filed: 24 Jan 22
Utility
Inhalable Imatinib Formulations, Manufacture, and Uses Thereof
23 Mar 23
The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
Ben Dake, Ralph Niven
Filed: 15 Aug 22
Utility
Inhalable Imatinib Formulations, Manufacture, and Uses Thereof
23 Feb 23
The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
Ben Dake, Ralph Niven
Filed: 11 Oct 22
Utility
Inhalable imatinib formulations, manufacture, and uses thereof
11 Oct 22
The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
Ben Dake, Ralph Niven
Filed: 14 May 20
Utility
Inhalable imatinib formulations, manufacture, and uses thereof
16 Aug 22
The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
Ben Dake, Ralph Niven
Filed: 14 May 20
Utility
Inhalable Imatinib Formulations, Manufacture, and Uses Thereof
14 Jul 22
The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
Ben Dake, Ralph Niven, Andrew D. Levin
Filed: 24 Jan 22
Utility
Nebulized Imatinib Formulations, Manufacture, and Uses Thereof
16 Jun 22
The invention relates to nebulized imatinib formulations, manufacture, and uses thereof.
Ben Dake
Filed: 3 Mar 22
Utility
Inhalable imatinib formulations, manufacture, and uses thereof
25 Jan 22
The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
Ben Dake, Ralph Niven, Andrew D. Levin
Filed: 14 May 20
Utility
Inhalable Imatinib Formulations, Manufacture, and Uses Thereof
2 Dec 20
The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
Ben Dake, Ralph Niven
Filed: 13 May 20
Utility
Inhalable Imatinib Formulations, Manufacture, and Uses Thereof
18 Nov 20
The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
Ben Dake, Ralph Niven, Andrew D. Levin
Filed: 13 May 20
Utility
Inhalable Imatinib Metabolite Formulations, Manufacture, and Uses Thereof
18 Nov 20
The invention relates to inhalable imatinib metabolite formulations, manufacture, and uses thereof.
Ben Dake, Ralph Niven
Filed: 13 May 20
Utility
Inhalable Formulations of Imatinib, Imatinib Metabolites, Imatinib Salts, Their Manufacture, and Uses Thereof
18 Nov 20
The invention generally relates to inhalable formulations of imatinib, imatinib metabolites, imatinib salts, their manufacture, and uses thereof.
Ben Dake, Ralph Niven
Filed: 13 May 20
Utility
Nebulized Imatinib Formulations, Manufacture, and Uses Thereof
18 Nov 20
The invention relates to nebulized imatinib formulations, manufacture, and uses thereof.
Ben Dake
Filed: 13 May 20
Utility
Inhalable Imatinib Formulations, Manufacture, and Uses Thereof
18 Nov 20
The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
Ben Dake, Ralph Niven, Andrew D. Levin
Filed: 13 May 20
Utility
Inhalable Imatinib Formulations, Manufacture, and Uses Thereof
18 Nov 20
The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
Ben Dake, Ralph Niven
Filed: 13 May 20
Utility
Inhalable Formulations for Kinase Inhibition
18 Nov 20
The invention relates to inhalable formulations configured to inhibit target combinations of kinases for the treatment of cardiovascular and pulmonary diseases such as pulmonary arterial hypertension (PAH).
Ben Dake
Filed: 13 May 20
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first